Advertisement

Topics

Companies Related to "The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma" [Most Relevant Company Matches] RSS

04:20 EDT 20th October 2018 | BioPortfolio

Here are the most relevant search results for "The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma" found in our extensive corporate database of over 50,000 company records.

Showing "Clinical Utility Thrombelastography Guiding Prophylaxis Venous Thromboembolism Following" Companies 1–25 of 5,200+

Relevant

Adamed Sp. z o.o.

Our priority is production of ethical drugs. We are leaders on the market of new generation drugs in many therapeutic groups such as cardiology, psychiatry, pulmonology, gynecology and treatment of urinal tract infections.We invest in research that is set to find effective and innovative original drugs which can be used for the most common diseases of our time, diabetes, venous thromboembolism (VT...


Venous Disease Coalition

The Venous Disease Coalition (VDC) is an alliance of more than 35 leading health professional societies and patient advocacy groups that have united around a common goal: To improve the survival rates and quality of life for individuals with, or at risk for, venous disease. The VDC plans to develop a national campaign to educate public and health care professionals in the U.S. about venous disease...

Guiding Stars

Since 2006, Guiding Stars has been leading the way in helping consumers make nutritious choices. The Guiding Stars program is a simple, easy-to-understand tool for making good nutritional choices and is designed to make a positive and lasting impact on public health. Guiding Stars is currently in more than 1,500 supermarkets including Food Lion, Hannaford,...


Guiding Stars Licensing Co.

Since 2006, Guiding Stars has been leading the way in helping consumers make nutritious choices. The Guiding Stars program is a simple, easy-to-understand tool for making good nutritional choices and is designed to make a positive and lasting impact on public health. Guiding Stars is currently in more than 1,500 supermarkets including Food Lion, Hannaford,...

Vnus Medical Technologies

VNUS Medical Technologies, Inc. is dedicated to providing innovative products for treatment of venous disease. Our mission is to help patients look and feel better with safe, fast and more effective treatments for venous disease. VNUS Medical Technologies, founded in 1995, is a public company and world leader in the development and commercialization of products for minimally invasive treatment of...

Stealth Therapeutics Inc.

Stealth Therapeutics was founded in 2006 for the purpose of designing and developing a portfolio of improved venous access devices. The technology is derived from the clinical practice of the company’s founder, Dr. Bradley Glenn. Dr. Glenn, a practicing interventional radiologist with strong interest and experience in venous access devices, guides Ste...

InterVene Inc.

InterVene Inc. has developed the first non-implantable, catheter-based, vein valve creation therapy. The product is designed to treat chronic venous insufficiency (CVI) in the deep veins - a severely under-treated disease that causes painful venous stasis ulcers and other debilitating symptoms in millions of Americans annually. For more information, visit www....

UTILITY therapeutics Limited

UTILITY therapeutics is focused on developing and commercialising antibiotics in the US, to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections. The World Health Organisation has stated that antibiotic resistance is one of the biggest threats to global health, food security, and development...

UTILITY therapeutics Ltd

UTILITY is focused on developing and commercialising antibiotics in the US, to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections. The World Health Organisation has stated that antibiotic resistance is one of the biggest threats to global health, food security, and development today.

Sapheon Inc.

Sapheon is an early stage medical device company whose mission is to develop new approaches for the treatment of vascular disease. Our current focus is on developing technology to improve the treatment of venous reflux disease. Sapheon's newly developed vein closure technology responds to the inadequacies of existing venous reflux treatment options by usin...

Venous Health Systems, Inc.

QRxPharma Limited

QRxPharma (ASX: QRX and OTCQX: QRXPY) is a clinical-stage specialty pharmaceutical company focused on the development and commercialisation of therapies for pain management and central nervous system (CNS) disorders. Based on a business strategy to expand the clinical utility and commercial value of marketed and/or existing compounds, QRxPharma's product portfolio includes both late and early sta...

Enpath Medical

Enpath Medical is a leading supplier of venous vessel introducers, providing these products worldwide since 1985. Our broad range of introducer products includes slittable and peelable introducers, various locking mechanisms, a variety of materials - including FEP and PTFE - and other proprietary features that can be customized to fit the specific needs of individual customers. Enpath has als...

iVeena Delivery Systems, Inc.

iVeena Delivery Systems, Inc. (iVeena) is a privately held biopharmaceutical company that develops innovative ophthalmology products. iVeena utilizes a proprietary intracapsular drug delivery platform to enhance a medication’s ocular bioavailability to anterior and posterior eye segments. The lead product delivers dexamethasone to treat post-cataract ...

Becker & Associates Consulting, Inc.

Becker & Associates Consulting, established in 2002, is among the leading scientific consulting firms in the United States. The Company specializes in guiding corporations through the clinical and regulatory process, and maintains perhaps the most highly regarded compliance practice for FDA-regulated products.

Dallas Thrombosis Hemostasis & Difficult Hematology Clinical Center

Thrombosis is clearly the most common cause of death in the United States. About two million individuals in the U.S.A. die each year from an arterial or venous thrombosis or the consequences. By comparison, about 540,000 individuals in the USA die each year from cancer. About 80% to 90% of all causes of thrombosis can now be defined with respect to cause. Of these, up to 90% of all patients ha...

20/20 GeneSystems, Inc

20/20 GeneSystems is dedicated to the identification, validation, and commercialization of novel protein biomarkers useful for detecting disease early and for guiding the selection and administration of therapy. 20/20 is addressing significant unmet needs for better diagnostics for cancer and autoimuune diseases (e.g. lupus). The utility of protein biomarkers for early detection of ovarian cancer ...

microscience

Microscience is a biotechnology company focussed on the discovery and development of innovative rationally designed vaccines for the prophylaxis and treatment of disease in areas of significant unmet clinical need. Microscience, which was founded in 1997, has used proprietary functional genomics and vaccine technology expertise as the basis of an expanding product portfolio. The Company’s secure...

Artesian Resources Corporation

Artesian Resources Corporation operates as the holding company of eight wholly-owned subsidiaries offering water, wastewater and other services on the Delmarva Peninsula. Artesian Water Company, the principal subsidiary, is the oldest and largest investor-owned public water utility on the Delmarva Peninsula and has been providing water service since 1905. ...

Tactile Medical

Tactile Medical headquartered in Minneapolis, MN is a leader in lymphedema and venous ulcer therapies, serving tens of thousands of patients throughout the U.S. The home therapy device company manufactures and provides products for patients with chronic edema, including the Flexitouch® System, an advanced pneumatic compression device and Entré System...

ReGen therapeutics Plc

The principal activity of ReGen Therapeutics Plc is the development and exploration of Colostrinin as a drug for the prophylaxis and treatment of Alzheimer's disease and other neurological disorders. Colostrinin is a proline-rich polypeptide complex isolated from ovine colostrinin. Colostrum is the mammal's first milk after the birth of an offspring.

Flexible Stenting Solutions, Inc.

Flexible Stenting Solutions Inc. (FSS) is a leading developer of third-generation flexible peripheral arterial, venous, neurovascular and biliary stents. Its fully connected stent has coupled technology with clinical needs by providing an atraumatic, highly durable and fatigue resistant stent with superior radial stiffness, flexibility and conformability. ...

D-Pharm Ltd

D-Pharm (http://www.dpharm.com) is a technology-driven biopharmaceutical company focused on the discovery and development of innovative proprietary drugs for the treatment of central nervous system disorders and cancer. D-Pharm is a leader in design and development of lipid-like medicine and its products are new chemical entities (NCEs) derived from its proprietary platform technology. The dru...

Oncogene Research projects

Today, OncogeneScience® based in Cambridge MA (at the original Applied bioTechnology facility) develops, manufactures, and markets high quality, ready-to-use cancer reagent systems to commercial and clinical research customers worldwide to further establish the clinical utility of these microtiter assays. Its core competencies include unparalleled microtiter plate assay expertise and a significan...

VenX, LLC

Headquartered in Nashville, TN, VenX, LLC is a privately held medical device company focusing on the development of proprietary methods to treat abnormal veins associated with venous insufficiency. Citing the limitations of the currently available treatments, VenX’s founders teamed up with clinical experts and design specialists from around the world ...


More From BioPortfolio on "The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks